Asia Biotech Live
LATEST UPDATES » Vol 24, No 01, January 2020 – Empowering the Patient - Personalization of Diabetes Management       » First of its kind Human Heart-in-a-Jar Model for therapeutic solutions       » China's National Vaccine Tracking System set to be completed in 2020       » China's amended drug administration law kicks in       » Human activity puts Chinese plant biodiversity at risk, study finds       » Contributory effects of each brain cell type in development of Alzheimer's Disease      
Bayer, NUS Enterprise partner to start Healthy Hearts, Healthy Aging initiative
Initiative to drive the adoption of health innovation which enables long-term prevention of stroke, heart attacks and other serious cardiovascular events

By 2050, one in four people in Asia and the Pacific will be over 60 years old. An increase in age is inevitably accompanied by a concurrent increase in chronic medical conditions like cardiovascular diseases (CVDs).

As the cause of more than 17 million deaths annually, with Asia accounting for about half of them, CVD is the world鈥檚 largest noncommunicable disease (NCD) by morbidity and mortality. This burden is projected to rise with the region鈥檚 ageing population.

Bayer in partnership with NUS Enterprise, the entrepreneurial arm of the National University of Singapore (NUS) announced a new initiative to drive adoption of health innovation in CVD prevention in seniors in the Asia-Pacific region.

The initiative - Healthy Hearts, Healthy Aging, comprises of a forum, report, among other initiatives, aims to bring healthcare experts, policy makers, innovators, academia, non-governmental organizations (NGOs) and corporations together to examine the role of health innovations in preventing serious cardiovascular (CV) events such as strokes and heart attacks in seniors living with CVD.

Bayer will draw on NUS Enterprise鈥檚 expertise and experience in engaging the regional startup ecosystem for innovation to develop a report which gathers research data and critical insights from multi-disciplinary teams of experts across the region.

The report will examine the CV health imperatives associated with ageing populations across the Asia-Pacific.

The report will also gather recommendations on how different stakeholders can collaborate to enhance the adoption of health innovation in the long-term preventive care of CVD patients. It is planned for a June 2019 completion.

Click here for the complete issue.

news Joining Forces to Elevate Asia's Healthcare Industry
news 4th Global Feed Summit draws Feed Producers, Technology Providers, Raw Materials Suppliers to Bangkok for Key Discussions
news 2nd China Pharma Digital Innovation Summit to be held in Shanghai
news 2nd China Healthcare Digital Innovation Summit to be held in Shanghai

About Us
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
Copyright© 2020 World Scientific Publishing Co Pte Ltd  •  Privacy Policy